Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Editor in Chief
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
3
result was found. Results that relate to
Sintilimab
A case of toxic epidermal necrolysis caused by sorafenib and sintilimab
Published on
Chinese Journal of Pharmacoepidemiology
2024,33(2):224-229.
781 times
420 times
DENG Lin
REN Chao
SUN Tao
LI Xi
GUO Shun
ZHOU Ang
Sorafenib
Sintilimab
Toxic epidermal necrolysis
Adverse drug reactions
Details
Evaluation of efficacy and safety of Sintilimab+Bevacizumab combined with PP regime in patients with advanced non-squamous non-small cell lung cancer
Published on
China Pharmacist
2024,27(1):93-99.
412 times
137 times
SHEN Junjie
JIN Jianwei
RUAN Zekun
ZHANG Weiping
Advanced non-squamous non-small lung cell cancer
Sintilimab
Bevacizumab
Efficay
Safety
Details
Real-world study of sintilimab combined with bevacizumab in patients with advanced hepatocellular carcinoma
Published on
China Pharmacist
2024,27(3):485-490.
289 times
371 times
SU Zhan
CHE Jinhui
PEI Ruifeng
Advanced hepatocellular carcinoma
Sintilimab
Bevacizumab
Clinical efficacy
Safety
Overall survival
Progression-free survival
Details